FIELD: medicine.
SUBSTANCE: method involves dividing cells by using agglutination. Required reagents comprise dextrane solution, anti-Glycophorin A-antibody, anti-CD15-antibody, anti-CD9-antibody, and antibodies selected from a group composed of anti-CD3-antibody, anti-CD72-antibody, anti-CD16-antibody, anti-CD4-antibody, anti-CD8-antibody and anti-CD2-antibody.
EFFECT: enhanced effectiveness in selecting blood cells of rare cell types with high output amount.
33 cl, 17 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION (VERSIONS), METHOD AND ASSEMBLY FOR SEPARATING CELLS | 2003 |
|
RU2346039C2 |
| METHOD OF PREPARING MONOCLONAL ANTIBODY RAISED AGAINST T-CELLS SURFACE ANTIGEN, MONOCLONAL ANTIBODY, PHARMACEUTICAL COMPOSITION AND DIAGNOSTIC REAGENT | 1997 |
|
RU2196178C2 |
| ANTI-CD 16 BINDING MOLECULES | 2006 |
|
RU2491294C2 |
| METHODS AND COMPOSITIONS FOR TREATING LUPUS | 2010 |
|
RU2607022C2 |
| SINGLE B-CELL CULTIVATION METHOD | 2011 |
|
RU2575569C2 |
| METHOD FOR PRODUCING HYBRID/CHIMERIC CELLS AND USING THEM | 2010 |
|
RU2536978C2 |
| METHOD OF CHEMILUMINESCENT COMPOUND-ASSISTED DETECTION OF ANTIBODY IN SAMPLE AND METHOD OF MEASURING CONCENTRATION AND/OR RELATIVE CONTENT OF SPECIFIC ANTIBODY IN SAMPLE | 1993 |
|
RU2132070C1 |
| METHOD OF CULTURING SINGLE B-CELL | 2011 |
|
RU2709531C2 |
| BIOLOGICAL MATERIALS AND APPLICATION THEREOF | 2006 |
|
RU2432363C9 |
| PHARMACEUTICAL COMPOSITION FOR IMMUNE DISEASE TREATMENT | 2000 |
|
RU2203682C2 |
